Evaxion A (EVAX) Cash from Operations (2020 - 2022)
Evaxion A (EVAX) reported Cash from Operations of 5190000.0 for Q2 2022, up 54.96% on a YoY basis from 3349259.07 in Q2 2021, and up 36.6% quarter-over-quarter from 8186000.0 in Q1 2022.
Evaxion A (EVAX) Cash from Operations (2020 - 2022) Analysis & Trends
Evaxion A has reported Cash from Operations for 3 years, with the latest figure at 5190000.0 in Q2 2022.
- For the quarter ending Q2 2022, Cash from Operations rose 54.96% year-over-year to 5190000.0; the trailing twelve-month figure through Jun 2022 stood at 42717000.0 (down 48.17% YoY), and the FY2025 full-year result was 6625000.0, up 49.57% from the prior year.
- Cash from Operations for Q2 2022 stood at 5190000.0, up from 8186000.0 in the prior quarter.
- The five-year high for Cash from Operations was 2950000.0 in Q1 2020, with the low at 17818000.0 in Q3 2021.
- Historically, Cash from Operations has averaged 7871625.0 across 3 years, with a median of 6635500.0 in 2020.
- Annual changes were most pronounced in 2021 — Cash from Operations slumped 122.22% — and 2022, when it soared 54.96%.
- Evaxion A's Cash from Operations stood at 8018000.0 in 2020, then slumped by 122.22% to 17818000.0 in 2021, then soared by 70.87% to 5190000.0 in 2022.
- The last three Cash from Operations figures came in at 5190000.0 (Q2 2022), 8186000.0 (Q1 2022), and 17818000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -5.19 Mn |
| Jun 30, 2022 | -5.19 Mn |
| Mar 31, 2022 | -8.19 Mn |
| Mar 31, 2022 | -8.19 Mn |
| Sep 30, 2021 | -17.82 Mn |
| Sep 30, 2021 | -17.82 Mn |
| Jun 30, 2021 | -11.52 Mn |
| Jun 30, 2021 | -11.52 Mn |
| Mar 31, 2021 | -4.04 Mn |
| Mar 31, 2021 | -4.04 Mn |
| Sep 30, 2020 | -8.02 Mn |
| Sep 30, 2020 | -8.02 Mn |
| Jun 30, 2020 | -5.25 Mn |
| Jun 30, 2020 | -5.25 Mn |
| Mar 31, 2020 | -2.95 Mn |
| Mar 31, 2020 | -2.95 Mn |